Icon

LYVISPAH - (5MG, 10MG, 20MG)

BACLOFEN None
5MG, 10MG, 20MG
Less Than $1000 mn
None None
None None
None None
LYVISPAH is a gamma-aminobutyric acid (GABA-ergic) agonist indicated for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. • LYVISPAH may also be of some value in patient with spinal cord injuries and other spinal cord diseases.
Yes
LYVISPAH Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.